Zhu S

ORCID: 0000-0002-0190-2626 · 59 papers in corpus
2023
PeerJ ·doi:10.7717/peerj.15048

Endometrial decidualization is a decidual tissue formed by the proliferation and re-differentiation of endometrial stroma stimulated by decidualization inducing factors. It is very important for the proper maintenance of pregnancy. Previous…

article 2023
Journal of nanobiotechnology ·doi:10.1186/s12951-023-01831-4

Endometriosis is an estrogen-dependent chronic inflammatory disease. Hormonal and surgical treatments are the most commonly used clinical therapies, but they have many sides effects or are traumatic to the body. Therefore, specific drugs fo…

2023
Heliyon ·doi:10.1016/j.heliyon.2023.e13821

ObjectiveTo compare the changes of metabolites between Low-level light therapy (LLLT) and combined oral contraceptive (COC) after treatment of primary dysmenorrhea (PD), and to compare and analyze the biological and biochemical effects of t…

2023
Journal of ovarian research ·doi:10.1186/s13048-022-01084-z

ObjectiveTo explore the association between ovulation induction drugs and ovarian cancer.DesignSystematic review and meta-analysis.SettingNot applicable.Patient(s)Women without ovarian cancer who ever or never underwent ovarian induction.In…

article 2023
International Immunopharmacology ·doi:10.1016/j.intimp.2022.109644

OBJECTIVE: To investigate the roles of the cGAS-STING signal pathway and autophagy in the disease progression of endometriosis and to explore the regulatory mechanism of the cGAS-STING signal pathway on autophagy. DESIGN: A case-control ex…

2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1295787

ObjectiveTo explore the cycle characteristics and pregnancy outcomes of progestin-primed ovarian stimulation (PPOS) using fixed versus degressive doses of medroxyprogesterone acetate (MPA) in conjunction with letrozole (LE) in infertile wom…

2023
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences ·doi:10.11817/j.issn.1672-7347.2023.230123

ObjectivesAs the cesarean section rate increases year by year, the treatment of previous cesarean scar defects (PCSD) poses a significant challenge. This study aims to evaluate the clinical value of preoperative magnetic resonance imaging (…

other 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.1030201

OBJECTIVE: To explore the relative factors for best ovarian response in patients undergoing assisted reproductive technology with the gonadotropin-releasing hormone antagonist protocol and to establish a nomogram prediction model of ovarian…

article 2022
Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.cn112141-20211229-00759

and anemia.

article 2022
BMC women's health ·doi:10.1186/s12905-022-02068-3

BACKGROUND: This retrospective study evaluated the clinical features of perineal endometriosis (PEM) and established a prognostic nomogram for recurrence probability in patients treated with surgical resection. METHODS: This study enrolled…

2022
Lasers in medical science ·doi:10.1007/s10103-021-03490-z

We aimed to compare low-level light therapy with oral contraceptive pills for pain relief and serum levels of nitric oxide and prostaglandin E2 in patients with primary dysmenorrhoea. This was a randomised, active comparator-controlled, mul…

review 2022
Reproductive biology ·doi:10.1016/j.repbio.2022.100664

Adenomyosis is a benign invasion/infiltration of endometrial glands and stroma in the uterine myometrium. The optimal choice of adenomyosis treatment remains a subject of discussion. For patients with adenomyosis without fertility requireme…

erratum 2022
BMC women's health ·doi:10.1186/s12905-022-02100-6
2022
International journal of women's health ·doi:10.2147/ijwh.s367051

BackgroundPrimary dysmenorrhea (PD) is one of the most common complaints in women of childbearing age. Therefore, this trial aimed to assess the efficacy and safety of low-power visible-light-activated photodynamic therapy (PDT) in the trea…

other 2022
Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.cn112141-20220520-00336

Objective: To investigate the efficacy and safety of dienogest (DNG) alone and gonadotropin-releasing hormone agonist (GnRH-a) combined with DNG sequential treatment to adenomyosis. Methods: The clinical data of 110 patients with adenomyosi…

2022
Open medicine (Warsaw, Poland) ·doi:10.1515/med-2022-0594

We conducted a systematic review and meta-analysis of all published data to determine the impact of estradiol pretreatment on reproductive outcomes and ovary stimulation characteristics for in vitro fertilization (IVF)/intracytoplasmic sper…

2022
Frontiers in medicine ·doi:10.3389/fmed.2022.864560

BackgroundWith the widespread application of assisted reproduction technology (ART) and increased pelvic inflammatory disease, the incidence of heterotopic pregnancy (HP) has risen. However, the risk factors and treatment of HP remain indef…

2022
BMC cancer ·doi:10.1186/s12885-022-09747-2

BackgroundOvarian cancer (OC) is among the deadliest malignancies in women and the lack of appropriate markers for early diagnosis leads to poor prognosis in most cases. Previous studies have shown that KAZN is involved in multiple biologic…

2022
BioMed research international ·doi:10.1155/2022/6708200

Primary dysmenorrhea (PD) is a prevalent problem in gynecologic clinics among adolescents and women of reproductive age. Several therapy modalities, including traditional Chinese medicine, are deemed adequate (TCM) and have been in practice…

2022
Experimental hematology & oncology ·doi:10.1186/s40164-022-00357-z

Uterine and ovarian cancers are the most common gynecologic cancers. N6-methyladenosine (m6A), an important internal RNA modification in higher eukaryotes, has recently become a hot topic in epigenetic studies. Numerous studies have reveale…

article 2022
Biochimica et biophysica acta. Molecular basis of disease ·doi:10.1016/j.bbadis.2022.166602

Fibrosis, angiogenesis and chronic inflammation are the inherent characteristics of endometriosis (EMS). The cellular heterogeneity of ectopic and non-ectopic endometrium by single-cell RNA-sequencing (scRNA-seq)at secretory phase without t…

2021
Frontiers in oncology ·doi:10.3389/fonc.2021.737943

The BTK inhibitors ibrutinib and acalabrutinib are FDA-approved drugs for the treatment of B cell malignances. Both drugs have demonstrated clinical efficacy and safety profiles superior to chemoimmunotherapy regimens in patients with chron…

article 2021
Scientific reports ·doi:10.1038/s41598-021-90112-x

Endometriosis (EMS) is a disease that shows immune dysfunction and chronic inflammation characteristics, suggesting a role of complement system in its pathophysiology. To find out the hub genes and pathways involved in the pathogenesis of E…

2020
Medicine ·doi:10.1097/md.0000000000022395

BackgroundPrimary dysmenorrhea (PD) occurs during menstrual cramps, and there is currently no pathological evidence. This disease severely affects the daily lives of young women. Acupuncture (ACU) and moxibustion are an excellent way to rel…

preprint 2020
·doi:10.22541/au.160372880.07417845/v1

Double-stranded DNA (dsDNA) sensor cyclic-GMP-AMP synthetase (cGAS) and its downstream interferon gene stimulator (STING) act as important immune monitoring media have become a research hotspot. cGAS-STING pathway may play a key role in the…